Kraig Biocraft Laboratories Secures Spider‑Silk Yarn Order From Global Performance Sports Brand

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has reached a major commercialization milestone by fulfilling an order for custom‑engineered spider‑silk yarns from a globally recognised performance sports apparel brand, under a confidential pilot‑development agreement. Though the order volume is small by design, the company says it represents one of the most significant steps in its history, as it begins delivering next‑generation spider‑silk super‑fibres for elite athletic applications. Kraig Biocraft is now converting its recombinant‑spider‑silk inventory into customer‑specified yarns, scheduled for shipment before the end of Q1. These materials are being delivered into a performance apparel development pipeline with extremely demanding technical criteria—including durability, tensile strength, elasticity and weight‑to‑performance ratios. The collaboration validates the company’s claim to be the first commercial entity to demonstrate scalable, high‑performance recombinant spider‑silk production using traditional sericulture techniques. In addition to this sports apparel pilot, Kraig Biocraft recently announced the production of specialty fibres for a major European fashion house and has expanded its manufacturing footprint in Southeast Asia—signalling that further orders are expected as the company scales. Founder & CEO Kim Thompson said: “This collaboration underscores the growing recognition of our material's potential in high‑value, high‑performance applications. We look forward to showcasing what our spider silk can deliver at the elite level of apparel design and performance.” With this order now underway, Kraig Biocraft is moving into a new phase where commercial partners transition from testing and validation into potential revenue‑generating product integration—a turning point years in the making. #SpiderSilk #PerformanceApparel #BiotechInnovation #KraigBiocraft #SlimScan #GrowthStocks #CANSLIM